Screener
Amphastar Pharmaceuticals AMPH Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's operating margin?
- Amphastar Pharmaceuticals (AMPH) reported operating margin of 15.7% in Q2 2026.
- How has Amphastar Pharmaceuticals's operating margin changed year-over-year?
- Amphastar Pharmaceuticals's operating margin decreased by 37.7% year-over-year, from 25.1% to 15.7%.
- What is the long-term trend for Amphastar Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's operating margin has grown at a 44.2% compound annual growth rate (CAGR), from 3.1% to 19.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Amphastar Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude